Sectoral Asset Management »

AgomAb Therapeutics NV shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $477k 44k 10.97

More positions owned by Sectoral Asset Management

Evommune Com Shs (EVMN)
Contineum Therapeutics Cl A (CTNM)
Shoulder Innovations Common Stock (SI)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Gilead Sciences (GILD)
UnitedHealth (UNH)
Amgen (AMGN)
Vertex Pharmaceuticals Incorporated (VRTX)
Insmed Com Par $.01 (INSM)
Argenx Se Sp Adr (ARGX)
Abbvie (ABBV)
Abbott Laboratories (ABT)
Merck & Co (MRK)
Regeneron Pharmaceuticals (REGN)

View all positions for Sectoral Asset Management

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
FMR
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management

View all funds holding AgomAb Therapeutics NV